
NASDAQIndustrialsIntegrated Freight & Logistics
最新数据
US$16.84
−US$0.51 · -2.94%
Cryoport, Inc. operates as a specialized service provider within the life sciences sector, delivering global temperature-controlled supply chain solutions across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Central to their offerings is Cryoportal, a proprietary cloud-based platform designed to streamline the entire logistics process. This robust system facilitates order processing, generates necessary documentation (including customs paperwork), coordinates courier services, offers real-time shipment tracking and monitoring, aids in issue resolution, and ensures adherence to regulatory compliance standards. To guarantee the integrity of sensitive materials during transit, Cryoport provides CryoPort Express Shippers, engineered to maintain the stability of biological commodities throughout their journey. Furthermore, their SmartPak Condition Monitoring System collects vital environmental data, which is then utilized to produce informative dashboards and essential validation reports for each shipment. Their product range also includes specialized containment solutions such as vacuum insulated aluminum dewars and advanced cryogenic freezer systems. Beyond transportation, the company offers extensive biological specimen management services. These encompass cryopreservation storage and ongoing maintenance, meticulous archiving, continuous monitoring, precise tracking, and efficient receipt and delivery of samples. They also manage the transport of frozen biological specimens to and from client facilities and oversee the inbound and outbound flow of these critical materials. Additionally, Cryoport extends its expertise through comprehensive logistics support and management services, alongside short-term consulting in both logistics and engineering. The company primarily caters to the biopharmaceutical, animal health, and human reproductive medicine industries. Founded in 1999, Cryoport's headquarters are situated in Brentwood, Tennessee.
前收盘价
US$16.84
−US$0.51 · -2.94%
盘后
US$16.84
US$0.00 · 0.00%
10月12日 19:30 ET
盘中时间采用ET。市场数据可能有所延迟。
Cryoport, Inc. operates as a specialized service provider within the life sciences sector, delivering global temperature-controlled supply chain solutions across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Central to their offerings is Cryoportal, a proprietary cloud-based platform designed to streamline the entire logistics process. This robust system facilitates order processing, generates necessary documentation (including customs paperwork), coordinates courier services, offers real-time shipment tracking and monitoring, aids in issue resolution, and ensures adherence to regulatory compliance standards. To guarantee the integrity of sensitive materials during transit, Cryoport provides CryoPort Express Shippers, engineered to maintain the stability of biological commodities throughout their journey. Furthermore, their SmartPak Condition Monitoring System collects vital environmental data, which is then utilized to produce informative dashboards and essential validation reports for each shipment. Their product range also includes specialized containment solutions such as vacuum insulated aluminum dewars and advanced cryogenic freezer systems. Beyond transportation, the company offers extensive biological specimen management services. These encompass cryopreservation storage and ongoing maintenance, meticulous archiving, continuous monitoring, precise tracking, and efficient receipt and delivery of samples. They also manage the transport of frozen biological specimens to and from client facilities and oversee the inbound and outbound flow of these critical materials. Additionally, Cryoport extends its expertise through comprehensive logistics support and management services, alongside short-term consulting in both logistics and engineering. The company primarily caters to the biopharmaceutical, animal health, and human reproductive medicine industries. Founded in 1999, Cryoport's headquarters are situated in Brentwood, Tennessee.
日内区间
当前US$16.84
52周区间
当前US$16.84
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
持有
估值
46
合理估值
情绪
70
看涨
风险
43
风险偏高
动量
69
动能增强
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
Cryoport, Inc. operates as a specialized service provider within the life sciences sector, delivering global temperature-controlled supply chain solutions across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Central to their offerings is Cryoportal, a proprietary cloud-based platform designed to streamline the entire logistics process. This robust system facilitates order processing, generates necessary documentation (including customs paperwork), coordinates courier services, offers real-time shipment tracking and monitoring, aids in issue resolution, and ensures adherence to regulatory compliance standards. To guarantee the integrity of sensitive materials during transit, Cryoport provides CryoPort Express Shippers, engineered to maintain the stability of biological commodities throughout their journey. Furthermore, their SmartPak Condition Monitoring System collects vital environmental data, which is then utilized to produce informative dashboards and essential validation reports for each shipment. Their product range also includes specialized containment solutions such as vacuum insulated aluminum dewars and advanced cryogenic freezer systems. Beyond transportation, the company offers extensive biological specimen management services. These encompass cryopreservation storage and ongoing maintenance, meticulous archiving, continuous monitoring, precise tracking, and efficient receipt and delivery of samples. They also manage the transport of frozen biological specimens to and from client facilities and oversee the inbound and outbound flow of these critical materials. Additionally, Cryoport extends its expertise through comprehensive logistics support and management services, alongside short-term consulting in both logistics and engineering. The company primarily caters to the biopharmaceutical, animal health, and human reproductive medicine industries. Founded in 1999, Cryoport's headquarters are situated in Brentwood, Tennessee.
日内区间
当前US$16.84
52周区间
当前US$16.84
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目(USD) | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 1.76亿 USD | 2.33亿 USD | 2.37亿 USD | 2.23亿 USD | 2.23亿 USD |
| 销货成本 | 9312.3万 USD | 1.34亿 USD | 1.33亿 USD | 1.26亿 USD | 1.26亿 USD |
| 毛利 | 8305.4万 USD | 9933.2万 USD | 1.04亿 USD | 9657.7万 USD | 9657.7万 USD |
| 研究与开发 | 1704.1万 USD | 1804万 USD | 1572.2万 USD | 1684.3万 USD | 1684.3万 USD |
| 销售、一般及管理费用 | 1.03亿 USD | 1.47亿 USD | 1.2亿 USD | 9756.3万 USD | 9756.3万 USD |
| 营业费用 | 1.2亿 USD | 2.14亿 USD | 1.36亿 USD | 1.14亿 USD | 1.14亿 USD |
| 利息支出 | 236.1万 USD | 550.3万 USD | 614.2万 USD | 468.9万 USD | 468.9万 USD |
| 折旧和摊销 | 2771.2万 USD | 3075.7万 USD | 2748.7万 USD | 2276.5万 USD | 2024.7万 USD |
| 营业利润 | −3680.6万 USD | −1.15亿 USD | −3190.4万 USD | −1782.9万 USD | −1782.9万 USD |
| 净利润 | 7830.1万 USD | −9958.7万 USD | −3733.3万 USD | −2.76亿 USD | −2.76亿 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化,并非 GoAI 建议。
平均目标
US$19.21
上涨空间 14.07%| 行动 | 生效日期 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股票拆分 | 2015年5月19日 | 1:12 | — | — |
股票拆分 | 2010年2月5日 | 1:10 | — | — |
股票拆分 | 2005年3月16日 | 8:5 | — | — |
已生效 2015年5月19日
1:12
已生效 2010年2月5日
1:10
已生效 2005年3月16日
8:5
报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI2438.19万0.00%2.3万亿 USD0.03%US$381.57-0.10%
iShares Russell 2000 ETFIWM2242.09万0.03%787.4亿 USD0.19%US$277.9-0.37%
Vanguard Extended Market ETFVXF936.08万0.01%954亿 USD0.05%US$233.52-0.63%
Dimensional - US Small Cap ETFDFAS531.95万0.02%338.69亿 USD0.31%US$78.17-0.23%
Schwab U.S. Small-Cap ETFSCHA455.44万0.02%218.24亿 USD0.03%US$32.66-0.40%
Vanguard Russell 2000 ETFVTWO455.27万0.02%180亿 USD0.06%US$112.27-0.35%
Dimensional - US Core Equity 2 ETFDFAC433.75万0.00%885.96亿 USD0.21%US$45.31-0.04%
U.S. Micro Cap Portfolio ETFDFMC272.91万0.04%75.58亿 USD0.43%US$57.70-0.20%
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
Vanguard Extended Market ETFVXF
Dimensional - US Small Cap ETFDFAS
Schwab U.S. Small-Cap ETFSCHA
Vanguard Russell 2000 ETFVTWO
Dimensional - US Core Equity 2 ETFDFAC
U.S. Micro Cap Portfolio ETFDFMCAI 生成内容及延迟市场数据仅供信息与教育用途,不构成投资建议。